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INTRODUCTION 
Certain of the biochemical reactions in adrenal steroid biosynthesis 
consist of hydroxylations of cholesterol to produce the biologically 
active steroids corticosterone, aldosterone, and cortisol. These reactions 
occur in the mitochondria, endoplasmic reticulum, and soluble fractions 
of the adrenal cell(Fig. 1). 
The initial reaction is the side chain cleavage of cholesterol to 
pregnenolone(1-5). This reaction occurs within the mitochondria. The 
pregnenolone must diffuse out of the mitochondria for the next reaction is 
catalyzed by the NAD-linked 3|3-ol dehydrogenase and A ketoisomerase. This 
reaction converts pregnenolone to progesterone(6,7) and takes place in the 
soluble-microsomal fraction. At this point, the biosynthetic scheme di¬ 
verges into two major pathways. In the one terminating with cortisol, a 
17 hydroxylase in the microsomal fraction forms 17o,-0H progesterone, which 
is then converted to 11 desoxycortisol(compound S) by a microsomal 21 
hydroxylase(6-9). For the final reaction, compound S enters the mitochondria 
again where 11(3 hydroxylase forms cortisol(6,10), the major glucocorti¬ 
coid in man. 
The second major pathway from progesterone starts with the formation 
(1) 

Figure 1. Biosynthetic Scheme in the Formation of Adrenal Corticosteroids 
from Cholesterol 
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of desoxycorticosterone(DOC) by the microsomal 21 hydroxylase. DOC enters 
the mitochondria for the last two reactions. The 11(3 hydroxylase(11) 
converts DOC to corticosterone(the major glucocorticoid in the rat). 
Finally, the 18 hydroxylase(12) converts corticosterone to aldosterone, 
the principal mineralocorticoid. All of the hydroxylase reactions are 
catalyzed by mixed function oxidases(see below) which require NADPH and 
molecular oxygen. In summary, three mitochondrial NADPH-dependent 
reactions are involved in corticosteroidogenesis: the side chain cleavage, 
11(3 hydroxylation, and C-18 hydroxylation. The other biosynthetic steps 
take place in the soluble cell fraction and endoplasmic reticulum. 
Adrenal cortex mitochondria are of especial interest because they 
contain two electron transport chains. In addition to the pathway asso¬ 
ciated with oxidative phosphorylation present in nearly all mitochondria, 
adrenal cortex mitochondria contain a Cytochrome P450 pathway which 
catalyzes mixed function oxidase reactions(13). The components of this 
pathway include NADPH(14), a flavoprotein(15,16), a non-heme iron 
containing protein called adrenodoxin(17), and Cytochrome P450(15,16,18). 
Molecular oxygen acts as the final electron acceptor(Fig. 2). Recently, 
various workers have found that the activity of the P450 pathway is 
associated with mitochondrial steroid hydroxylation, i.e., the cholesterol 
side chain cleavage and the 11(3 and C-18 hydroxylations. The stoichiometric 
relationship between the P450 pathway and steroid biosynthesis is such 
that 1 mole of steroid is hydroxylated for each mole of NADPH and oxygen 
consumed. 
Even before the significance of the P450 pathway was known, the 
(3) 

Figure 2. Relationship Between the Classic Electron Transport and P450 
Pathways in Rat Adrenal Mitochondria. 
P450 Pathway 
<*) 

important requirement of NADFH in the steroid biosynthetic reactions was 
demonstrated(14,20,23). Workers postulated that the mechanism of action 
of adrenocorticotrophic hormone(ACTH) was via pathways causing an increase 
in the concentration of NADPH. Haynes and Berthet(22) and subsequently 
McKerns(21) suggested that ACTH activated adenyl cyclase and the cyclic 
3'5' adenosine monophosphate (cAMP) formed enhanced phosphorylase activity. 
Increased amounts of glucose-6-P0^ were metabolized via the hexose 
monophosphate shunt(HMS) wherein glucose-6-P0 dehydrogenase(G6PD) and 
4 
other NADP-linked enzymes generated increased levels of NADPH. Other 
workers(24,25) found that ACTH caused only a direct increase in activity 
of G6PD. In either case, an increase in NADPH was thought to result, 
thus leading to enhancement of corticosteroidogenesis. 
Although it was known that G6PD and the HMS were localized in the 
extramitochondrial soluble cell fraction several of the hydroxylations 
are mitochondrial(28). None of the workers postulated mechanisms 
whereby NADPH produced outside the mitochondria could gain access to the 
intramitochondrial space. It had long been known that the intact mito¬ 
chondrial membrane is essentially impermeable to the pyridine nucleo¬ 
tides (26, 27) , yet McKerns felt that the HMS pathway played a central 
role in providing NADPH for steroid biosynthesis(28). Brownie and Grant 
(11) had shown that certain Krebs cycle intermediates such as isocitrate, 
O'-ketoglutarate, and malate could support mitochondrial 113 hydroxy- 
lation. Presumably these substrates penetrate the mitochondrial membrane 
and are metabolized to yield NADPH. 
The demonstration of the P450 pathway led to the elucidation of its 
relationship to the classic electron transport chain and oxidative 
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phosphorylation. It has been shown that the two electron transport path¬ 
ways are connected by a transhydrogenase which reduces NADP at the expense 
of NADH. The reaction is enhanced in the presence of ATP or high 
energy intermediates of oxidative phosphorylation(19). (See Fig. 2) 
Because this pyridine nucleotide transhydrogenase is dependent on 
energy, it is called the energy linked transhydrogenase(ELTH). Ernster 
and Lee(29) proposed the following explanation of the reaction: 
+ _ + 
NADH + NADP + X - NAD + NAD PH + X 
where X represent a non-phosphorylated high energy intermediate. In 
the absence of X, the reaction has an equilibrium constant(K) of 0.79 
and therefore is almost freely reversible. However, in the presence of 
X the equilibrium constant( K= (NAD)(NADPH)/(NADH) (NADP) ) may be as 
high as 480. In other words, energy drives the reaction far to the side 
of NADPH formation. In this manner, the ELTH can provide NADPH for steroid 
hydroxylation from intramitochondrial sources of NADH. In the absence 
of energy, this pathway is still functional but to a much lesser degree. 
The ELTH thus provides one mechanism to explain the observations of 
Brownie and Grant(see above) and others that Krebs cycle intermediates 
metabolized by NAD-linked dehydrogenases can support steroid hydroxylation 
(30-32). In addition, work by Harding showed that uncouplers of 
oxidative phosphorylation inhibited succinate supported 113 hydroxylation 
(33). Likewise, Sauer demonstrated that steroid hydroxylation supported 
by 3-OH butyrate and a-ketoglutarate was strictly dependent upon the ELTH 
since KCN and rotenone, agents which inhibit the respiratory chain, 
completely abolished 113 hydroxylation(34). This work conclusively 
(5) 

demonstrates that the ELTH pathway is available only in the presence of 
energy. Furthermore, the significance of the ELTH is manifest in steroid 
hydroxylation supported by NAD-linked substrates, clearly demonstrating 
the functional dependence of steroidolgenesis upon oxidative phosphorylation. 
The pyridine nucleotide transhydrogenation is only one of several 
reactions which generate intramitochondrial NADPH for steroid hydroxy- 
lation. In addition, there are non-energy dependent mechanisms to make 
NADPH directly available for mitochondrial steroid hydroxylations. 
Such direct reactions could be operative in complete independence of 
oxidative phosphorylation, a situation which might be important when 
maximal rates of both steroid hydroxylation and ATP formation were 
required. These reactions are catalyzed by NADP-linked isocitric dehydro¬ 
genase (ICDH) and malic enzyme(ME). 
The existence of a mitochondrial NADP-linked isocitric dehydrogenase 
was first demonstrated in liver tissue by Hogeboom and Schneider(35) and 
subsequently verified by Ernster and Navazio(36) and others(37). These 
workers were able to show that about 10% of the total NADP-linked ICDH 
activity was mitochondrial whereas the remainder was in the soluble fraction. 
Schneider and Hogeboom(38) demonstrated a similar distribution using 
human placental tissue. In the human adrenal, Studzinski and his colleagues 
gave evidence that only 3% of the NADP-linked ICDH was mitochondrial, 
and the rest was in the soluble fraction(24). In the rat adrenal Guerra 
et. al.(30) demonstrated NADP-linked ICDH activity; and Sauer showed 
that isocitrate supported 11(3 hydroxylation is unaffected by respiratory 
(6) 

chain inhibitors(34) implicating high activity of the mitochondrial NADP- 
linked ICDH. In contrast, bovine adrenal mitochondria do not seem to 
utilize isocitrate as well as the rat; and in fact Goebell et.al.(39) 
have shown that over 907o of NADP-1 inked ICDH is extramitochondrial in 
bovine adrenals. Although isocitrate is known to be a good substrate 
for steroid hydroxylation, the available data show that differences- 
exist regarding the contribution by the NAD and NADP linked enzymes in 
various animals(11,40). Thus, the rat adrenal seems to have a high 
activity of the NADP-linked ICDH, whereas bovine and human adrenal mito¬ 
chondria rely more upon the NAD linked enzyme and the ELTH to support 
steroid hydroxylation within the mitochondria. 
In addition to isocitrate, malic acid constitutes another Krebs cycle 
intermediate which can be metabolized by a mitochondrial NADP-linked 
enzyme. Malic enzyme(ME) was originally described by Ochoa(41), and 
Hsu and Lardy eventually isolated and characterized the enzyme from pigeon 
liver(42). Malic enzyme catalyzes the following reaction: 
Mn"r+ or Mg ^ ^ 
L-Malic acid + NADP <---> Pyruvate + CO2 + NADPH 
Malate is also metabolized by the mitochondrial NAD-linked malate 
dehydrogenase(MDH) to produce NADH and oxaloacetate. 
Investigators have previously ascribed a role for ME in gluconeo- 
genesis by suggesting that it provides oxaloacetate by converting pyruvate 
to malate which is then hydrogenated to oxaloacetate, a precursor of 
phosphoenolpyruvate(46-48). Others suggested that ME had a functional 
role in lipogenesis by providing sources of NADPH(43-45). 
Studzinski et.al.(24) studied several NADP-linked dehydrogenases in 
the human adrenal and found that ME had such an extremely low activity as 
(8) 

to be barely measureable. Furthermore, the detectable ME activity was 
limited to the soluble fraction of the cell. In contrast, Simpson and 
Estabrook provided evidence in bovine adrenal mitochondria that ME was 
the major source of NADPH during malate and succinate supported steroid¬ 
ogenesis (49) . With ME, as with NADP-linked ICDH, animal differences 
were noted. Using rats, Purvis proposed that ME was a minor source of 
NADPH in mitochondrial 11(3 hydroxylation as opposed to bovine mito- 
chondria(40). Furthermore, Peron and Tsang felt that ME was relatively 
unimportant in that malate was oxidized mainly via the NAD-linked malate 
dehydrogenase(50). Recently, however, Sauer was able to stimulate a 
malic enzyme-like activity* in rat adrenal mitochondria by the addition 
of orthophosphate(P^) or arsenate(As)(34). In the absence of P^ or As 
his findings were similar to.those of Purvis in that the uncoupler- 
sensitive malate dehydrogenase was the major pathway for malate oxidation. 
However, upon the addition of P^, there was an uncoupler-insensitive 
stimulation of steroid hydroxylation implying that malate was producing 
NADPH directly. Thus, in contrast to bovine mitochondria, rat adrenal 
mitochondria require the presence of P^ or As for malic enzyme activity 
to become manifest(49,51,52). 
In summary then, rat, bovine, and perhaps human adrenal mitochondria 
show evidence that malate can be metabolized by non-energy dependent 
mechanisms in the production of intramitochondrial NADPH for steroid 
hydroxylation. The role of ME may therefore be similar to NADP-linked 
ICDH; together they constitute another mechanism (in addition to the 
* Malic enzyme-like activity is defined as the production of pyruvate and 
NADPH from malate. 
(9) 

energy linked and non-energy linked transhydrogenases) whereby NADPH may 
be generated within the mitochondria. 
Because ME has been shown to be present both within the mitochondria 
and in the soluble part of the adrenal cell, workers have postulated a 
shuttle mechanism to effect a net transfer of NADPH across the mitochondrial 
membrane using malate as the carrier molecule(53). The mechanism is 
essentially similar to that described originally by Boxer and Devlin(54) 
and more recently by Estabrook and Sacktor(55) in tissues other than the 
adrenal. Simpson and Estabrook have provided initial data that a malate 
shuttle may be operative in bovine adrenal cortex mitochondria(53). It 
has been suggested in rat adrenal mitochondria(56), but subsequently 
evidence was provided that it did not occur(50). As pointed out by other 
workers, the existence of a shuttle mechanism requires the presence of 
the enzyme both in the mitochondria and in the extra-mitochondrial soluble 
fraction. The enzyme must be capable of catalyzing both the forward and 
reverse reactions. In addition, the substrates which act as carriers for 
the pyridine nucleotides must be readily permeable to the mitochondrial 
membrane. In this manner, a cytosol malic enzyme would generate malate 
from pyruvate, CO2, and extramitochondrial NADPH. The mitochondrial ME 
could then oxidize malate back to pyruvate, CO2, and intramitochondrial 
NADPH--thus effecting the net transfer of reducing equivalents across the 
mitochondrial membrane. Such a mechanism could utilize the NADPH gener¬ 
ated by the hexose monophosphate shunt and would substantiate McKerns' 
proposal(see p.3) that the HMS must play a central role in providing 
NADPH for steroid biosynthesis(28). 
(10) 

At present, the available data regarding non-energy dependent 
mechanisms for intramitochondrial accumulation of NADPH are incomplete, 
and different opinions exist concerning the contribution of NADP-linked 
ICDH and ME to adrenal corticosteroidogenesis. Furthermore, the relation¬ 
ship between these and other NADPH producing mechanisms needs clarifi¬ 
cation. The existence of several non-energy dependent enzymatic path¬ 
ways may indeed imply that regulatory factors favor one pathway over 
another. The additional intriguing possibility of a malate shuttle has 
been proposed in bovine adrenals. 
This project was therefore begun with the purpose of further exploring 
and clarifying the role of non-energy dependent mechanisms in intra¬ 
mitochondrial NADPH formation for adrenal steroid biosynthesis. Certain 
details of NADP-linked ICDH and ME have not been examined in the past, 
and their relative contribution to steroidogenesis is unclear. In addition, 
certain features of substrate entry and efflux from mitochondria were 
examined. Finally, because the possibility of an NADPH shuttle system 
has been raised, attempts were made to demonstrate the existence of both 
an isocitrate and malate shuttle. In summary, then, the emphasis in this 
thesis is placed on the non-energy dependent mechanisms operative in the 
intramitochondrial production of NADPH for steroid hydroxylations in the 
rat adrenal gland. 
(11) 

MATERIALS AND METHODS 
Male Sprague-Dawley rats weighing 150-200 grams were used in these 
experiments. The rats were fed a normal laboratory chow ad_ libitum. In 
a typical experiment, 6-12 rats were killed by decapitation. The adrenals 
were quickly removed, chilled in ice cold 0.25 M Sucrose and adherent fat 
dissected away. The cleaned glands were then homogenized at 0-4° Cent, 
in 8 ml. of a medium containing 0.25 M Sucrose, 1 mM ethylenediamine- 
tetraacetate (EDTA), 30 mM TRIS-HC1, and 17, bovine serum albumin (pH 7.4) 
with 15 passes of a Teflon pestle in a 10 ml. glass homogenizer. Low 
speed centrifugation at 600g for 10 minutes removed nuclei, unbroken cells, 
and capsule fragments. The supernatant was decanted and stored on ice 
while the pellet was re-homogenized in 6 ml. of medium and centrifuged 
again. The combined supernatant solutions were centrifuged at 5200g for 
20 minutes. The mitochondrial pellet was washed twice by resuspension 
in 3 ml. of medium and centrifuged at 5200g for 10 minutes. The final 
mitochondrial pellet was resuspended in 0.5-1.0 ml. of medium for use in 
the experiments. After correcting for protein content of the medium, the 
usual yield of mitochondrial protein was 0.5-1.0 milligram(mgm.) per pair 
of glands. Protein was determined by the Biuret method(57). 
(12) 

Sonication was carried out using a Model W185D Sonifier Cell Disruptor 
manufactured by Branson Sonic Power Company. Subcellular fractions were 
diluted 1:4 with 0.25 M Sucrose and sonicated at a power setting of 2-4 
for 30 second periods per minute over 5 minutes at 0-43 Cent. Micro- 
somes were isolated by centrifuging the supernatant from the 5200g-20 min. 
spin at 100,000g for 60 minutes. The microsomal supernatant was the 
soluble fraction. 
Enzyme distribution experiments were done on sonicated subcellular 
fractions. NADP-linked ICDH activity was determined by spectrophotometric 
reduction of NADP in the presence of 8 mM d-isocitrate, 1 mM MnCl2, 
0.1 M TRIS-HC1 pH 7.4, and 33 mM NADP using a Gilford Model 2000 Recording 
Spectrophotometer at 340 mp,. Malic enzyme activity was measured in the 
same manner using 10 mM malate, 10 mM MgCl?, 0.1 M TRIS-HC1 pH 7.4, and 
20 mM NADP. The reaction was started by the addition of substrate. 
Blank cuvettes contained all additions except substrate. 
Incubations and substrate efflux experiments were carried out in a 
medium containing 50 mM sucrose, 20 mM KC1, 1 mM EDTA, 30 mM TRIS-HC1 
pH 7.4, and 17o bovine serum albumin. When used, desoxycorticosterone 
and rotenone were added as ethanolic solutions. Substrate concentrations 
for d-isocitrate and 1-malate were 10 mM. & N solutions were prepared 
immediately prior to use with 0.05 M TRIS-HC1 pH 8.6. 
In a typical substrate efflux experiment, 2 flasks containing 5-8 ml. 
of a medium with about 0.3 mgm. mitochondrial protein per ml. were incub¬ 
ated for 12-48 minutes at 37° Cent. Flasks were preincubated for several 
minutes, and the reaction started with the addition of mitochondria. 
(13) 

Orthophosphate was added at variable times during the incubation. 0.5 ml. 
aliquots for a-ketoglutarate and pyruvate determinations were removed with 
a pipette at timed intervals and immediately centrifuged for 15 seconds 
in a Fisher Model 59 Semi-micro centrifuge. This would form a compact 
mitochondrial pellet from which the supernatant was decanted, iced, and 
assayed, a-ketoglutarate was determined by spectrophotometric oxidation 
of NADPH at 340 mp, using glutamic dehydrogenase(Calbiochem) . Pyruvate 
was determined in the same manner using lactic dehydrogenase(C. F. Boeh- 
ringer). 
Mitochondrial swelling experiments utilized 90 mM NH^-malate pH 7.6, 
and light scattering was read spectrophotometrically at 600 mp. In the 
14 14 
C -malate uptake experiments, 50 p,Curies of C -L-malic acid, specific 
activity 9.1 mCuries/mMole(New England Nuclear), was diluted so that the 
flask concentration of 10 mM malate had a theoretical activity of 317,500 
counts per minute(CPM)/ml. of incubation medium. Tritiated water(New 
England Nuclear) had an activity of 133,000 CPM/ml. incubation medium. 
The mitochondria were centrifuged as in the substrate efflux experiments; 
the pellet was then lysed with 0.1 ml. of 7% perchloric acid and counted 
for radioactivity in a Model 2002 Packard Tricarb Scintillation Spectro¬ 
meters Bray's solution was used as counting medium. 
Soluble fraction malic enzyme for the malate shuttle experiments was 
partially purified from pooled 5200g-20 min. supernatants which were then 
centrifuged at 100,000g for 60 minutes. (NH^^SO^ fractionation of the 
soluble fraction was carried out at 0-4° Cent. The fractionated protein 
was centrifuged for 10 min. at 15,000g, then redissolved in 0.1 M TRIS-HC1 
pH 7.4. The fractions containing the most enzyme activity were pooled and 

dialyzed for 24 hours against 0.03 M TRIS-HC1 pH 7.4 with 2 mM mercap- 
toethanol at 0-4° Cent, with 3 exchanges of fluid. The enzyme was then 
concentrated in solid sucrose for 8-12 hours to reduce the volume and 
redialyzed for several hours to remove most of the sucrose. After re¬ 
assay for activity, the enzyme was used in the shuttle experiment. In 
addition to the incubation mix, the following reagents were included in 
the shuttle experiment: 300 |jbM DOC, 10 mM Na-pyruvate, 50 mM NaHCO^, 
10 mM MgCl?, 1 mM Arsenite, 2 mM orthophosphate(P^), approximately 0.8 
mgm. mitochondrial protein/ml. total incubation medium, and an NADPH 
generating system consisting of 0.5 mM NADPH, 10 mM glucose-6-P0^, and 
glucose-6-P0^ dehydrogenase. The reaction mixture was preincubated at 
37° Cent, for 15 minutes and the mitochondria added at zero time. The 
reaction was stopped after 15 minutes by icing and addition of 1.0 ml. of 
0.5% HgC^. After dilution with glass distilled water, assay for 
corticosterone was carried out by a modification of the sulfuric acid 
fluoresence method(58). 
Desoxycorticosterone was obtained from the Sigma Chemical Co. The 
enzymes were purchased from either Calbiochem or C.F. Boehringer and 
Soehne, Mannheim, Germany. Nucleotides were purchased from the Sigma 
14 3 
Chemical Co. and Calbiochem. C -L-malic acid and H -water were obtained 
from New England Nuclear. Bovine serum albumin was Pentex recrystallized. 
Para-iodobenzylmalonate was purchased from K & K Laboratories, Inc. 
(15) 

ISOCITRIC DEHYDROGENASE 
1. Distribution of Enzyme Activity 
68% of the NADP-linked ICDH activity in the rat adrenal cell is 
localized in the 100,000g-60 min. soluble supernatant fraction. After 
sonication, the mitochondrial fraction shows 177, and the nuclei + waste 
fraction 7% of the total activity. The activities of each fraction are 
shown in Fig. 3 and Table I. The actual activity of the nuclei + waste 
fraction is probably less because this fraction included the mitochondrial 
washings. Latent enzyme activity was released by sonication. This 
process structurally disrupts whole cells, mitochondria, and other cellu¬ 
lar constituents so that enzyme activity contained within equilibrates 
TABLE I. SUBCELLULAR DISTRIBUTION OF NADP-LINKED ISOCITRIC DEHYDROGENASE 
FRACTION TOTAL 
up, moles 
ACTIVITY 
NADPH/min. 
% TOTAL ACTIVITY 
RECOVERED 
SPECIFIC ACTIVITY 
mpmoles NADPH/min. 
mgm. protein 
Initial Homogenate 5710 100 173 
Nuclei + Waste 386 6.8 49.5 
Mitochondria 970 17.0 104. 
Microsomes 145 2.5 34.5 
Soluble 3860 67.6 391. 
The 5 subcellular fractions were isolated from the adrenal glands of 
8 rats. Each fraction was diluted 6 fold and sonicated for 5 min. at 30 sec. 
intervals at 0-4~ C. ICDH activity was measured spectrophotometrically at 
340 mp, by the rate of reduction of 30 mM NADP in the presence of 8 mM isocitrate, 
1 mM MnC^, o.l M TRIS-HCl, and the sonicated enzyme. 
(16) 
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Figure 3. Subcellular Distribution of NADP-Linked Isocitric 
Dehydrogenase in the Rat Adrenal Cell. 
The 5 subcellular fractions were isolated from the adrenal 
glands of 8 rats. Each fraction was diluted 6X and sonic¬ 
ated for 5 min. at 30 sec. intervals at 0-4° C. ICDH 
activity was measured spectrophotometrically at 340 mjj, by 
the rate of reduction of 30 mM NADP in the presence of 
8 mM isocitrate, 1 mM MnCl2, 0.1 M TRIS-HC1, and the 
sonicated enzyme fractions. 
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with the soluble phase. Note that ICDH is extremely abundant in the 
soluble cell fraction and seems to have about a 4 fold higher specific 
activity than the mitochondrial enzyme. 
2. Kinetics of NADP-Linked Isocitric Dehydrogenase 
The different locales of the soluble and mitochondrial ICDH suggests 
that these are two different enzymes. While this point was not extensively 
studied, further kinetic studies were done using the sonicated mitochondria 
and the soluble supernate. The soluble supernatant enzyme had a Km for 
d-isocitrate of about 19 |j,M whereas the ^ for the mitochondrial ICDH was 
21-57 [jlM. Unfortunately the enzymes were not purified sufficiently to 
do more accurate and detailed kinetics, but even with these data it can 
be seen that both enzymes have very small Michaelis constants for d-isocitrate. 
A Lineweaver-Burke plot of the soluble ICDH is shown in Fig. 4. 
3. Isocitric Dehydrogenase Activity by Q'-Ketoglutarate Efflux 
Another technique for assessing mitochondrial isocitrate oxidation 
is measurement of efflux of the product, cv-ketoglutarate. Most Krebs cycle 
intermediates are known to be permeable to the mitochondrial membrane 
to varying degrees. It was found that a-ketoglutarate will diffuse out 
of the mitochondria into the incubation medium at a constant rate during 
isocitrate oxidation. Fig. 5 shows the rate of a-ketoglutarate efflux from 
mitochondria utilizing exogenous isocitrate in the absence of inhibitors 
of oxidative phosphorylation. The presence of 1 mM arsenite inhibits the 
oxidation of a-ketoglutarate to succinate so that the resulting accumulation 
(18) 

Figure 4. Lineweaver-Burke plot of Soluble Fraction ICDH 
Soluble fraction ICDH activity was measured spectrophoto- 
metrically at 340 mg, by rate of NADPH formation in the 
presence of 1 mM MnC^, 0.1 M TRIS-HC1, 30 mM NADP, var¬ 
iable isocitrate concentration, and the sonicated enzyme. 
Approximate for d-isocitrate = 0.019 mM 
20 
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Figure 5. Effects of ADP + P. and Arsenite upon 
Q'-Ketoglutarate Efflux 
Flasks were incubated at 37° C. for the times shown. Flask 
contents included: 10 mM isocitrate, 2 mM P^, 0.4 mM ADP, 
1 mM arsenite, and 0.5 mgm. mitochondrial protein/ml. 
Ck'-Ketoglutarate was measured by enzymatic methods. 
(20) 

of Q-ketoglutarate should enhance diffusion out of the mitochondria. In 
the other flask the presence of ADP + P^ increased the rate of isocitrate 
oxidation by providing the necessary substrates for oxidative phosphory¬ 
lation. Note that the rate of Q-ketoglutarate efflux is not only reason¬ 
ably constant but is not augmented by arsenite. This may mean that 
during isocitrate oxidation Q-ketoglutarate is produced in sufficient 
quantity to completely saturate the mechanism which mediates Q-ketoglutarate 
efflux. An enhancement of efflux would therefore not be expected with a 
greater quantity of intramitochondrial Q'-ketoglutarate formed by the 
effect of arsenite. 
Fig. 6 demonstrates the effect of steroid hydroxylation on the rate 
of Q'-ketoglutarate efflux from KCN-inhibited mitochondria. NADPH pro¬ 
duced by NADP-linked ICDH is available to the P450 pathway. In the 
presence of adequate steroid substrate this pathway therefore acts as an 
electron sink by reoxidizing the NADPH made available by isocitrate 
oxidation. 2 mM KCN was added to inhibit cytochrome oxidase and thus 
diminish the contribution of the NAD-linked malic dehydrogenase. In 
addition, 1 mM arsenite is present to maximize Q-ketoglutarate efflux. 
Fig. 6 shows that the presence of DOC stimulated Q-ketoglutarate efflux 
originating from the NADP-linked pathway. 
According to Chappell, isocitrate entry into the mitochondria requires 
the additional presence of malate and inorganic phosphate(59). Fig. 7 
shows Q-ketoglutarate efflux ± DOC and the effect of malate and P.. There 
does not seem to be any appreciable difference in the rate of Q-ketoglut¬ 
arate efflux before or after the addition of these 2 factors. Under these 
(21) 
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Figure 6. Effect of DOC upon Q'-Ketoglutarate Efflux from KCN 
Inhibited Mitochondria During Isocitrate Support. 
Two flasks were incubated at 37° C. with % ml. aliquots removed 
at times shown. Incubation mixture contained 10 mM isocitrate, 
2 mM KCN, 1 mM arsenite, ± 100 p,M DOC, and 0.36 mgm. mitochondrial 
protein/ml. Reaction was stopped by centrifuging down the 
mitochondria. Assay of cy-ketoglutarate in the supernatant fluid 
was carried out by enzymatic methods. 
(22) 
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Figure 7. Effect of P^ and Malate on ± DOC Stimulated a-Ketoglutarate 
Efflux from Isocitrate Supported Mitochondria. 
Two flasks were incubated at 373 C. with \ ml. aliquots removed 
at 4 min. intervals. Final incubation mixture contained 10 mM 
isocitrate, 1 mM arsenite, ± 100 uM DOC, 2 mM P^, 0.2 mM malate, 
and 0.435 mgm. mitochondrial protein/ml. The reaction was stopped 
by centrifuging down the mitochondria and assaying the super- 
nate . c^-ketoglutarate was measured by enzymatic methods. 
(23) 

conditions, no evidence was found for enhanced isocitrate entry based on 
Q'-ketoglutarate efflux. 
4. Partial Purification of ICDH and Shuttle Experiment 
The presence of a highly active NADP-linked ICDH in the soluble cell 
fraction and evidence that cv-ketoglutarate produced during isocitrate 
oxidation diffused out of the mitochondria led to speculation regarding 
a possible isocitrate shuttle system. If such a system were operative, 
intramitochondrial NADP-linked isocitrate oxidation would produce intra- 
mitochondrial NADPH for steroid hydroxylation. The O'-ketoglutarate also 
formed could then diffuse into the soluble cell fraction. The highly 
active extramitochondrial NADP-linked ICDH could utilize NADPH and HCO^ to 
reform isocitrate. In this manner, isocitrate could re-enter the mito¬ 
chondria and effect a net transfer of reducing equivalents across the 
mitochondrial membrane. Experiments designed to demonstrate this possi¬ 
bility were attempted. A crude purification of soluble NADP-linked ICDH 
activity was undertaken as follows: The fractions from the 100,000g-60 min 
supernatant fluid precipitating between 58 and 75% saturation with ammon- 
+ 
ium sulfate were dialyzed against 0.1 M TRIS-HC1 buffer to remove NH^. 
These fractions, which possessed the highest NADP-linked ICDH activity, 
were incubated with mitochondria, DOC, and the reactants necessary for the 
conversion of a-ketoglutarate to isocitrate. However, no steroid hydroxy- 
lation above control rates could be demonstrated. This experiment was 
repeated on several occasions, but each time negative results were obtained 
The failure of this shuttle to support steroid hydroxylation _in vitro 
does not speak against its existence _in vivo. Despite the fact that the 
(2U) 

reverse reaction is kinetically unfavorable, we were able to demonstrate 
spectrophotometrically that commercial NADP-linked ICDH catalyzed the 
oxidation of NADPH in the presence of Qf-ketoglutarate (Fig. 8). Note that 
the reverse reaction is completely dependent on HCO^ and NADPH. It 
seems therefore that the reverse reaction is biochemically possible, 
but that our in vitro incubation was not sufficiently sensitive to detect 
the small amount of isocitrate formed. At the present time, we cannot 
assess the degree to which this isocitrate shuttle is operative _in vivo. 
In summary, the following facts may be derived from the results of 
the preceding experiments: 
1) NADP-linked ICDH is found both in the mitochondria and in the 
soluble fraction of the rat adrenal cell. 
2) ICDH is a highly active mitochondrial enzyme capable of 
supporting high rates of steroid hydroxylation. 
3) a-ketoglutarate formed by NADP-linked ICDH can diffuse out of 
the mitochondria even in the absence of arsenite. This efflux is augmented 
by steroid hydroxylation. 
4) ICDH can catalyze the reverse reaction (oxidize NADPH and form 
isocitrate), but under our incubation conditions this does not occur at 
a rate sufficient to support steroid hydroxylation. 
(25) 

Figure 8. Spectrophotometric oxidation of NADPH at 340 mp by commercial 
NADP-linked ICDH. 
=N= 
Cuvette contained 10 mM Q'-ketoglutarate, 10 mM Mn , 1 mM 
arsenite, ± NADPH(NADH added in place of NADPH), ± 50 mM 
HCO^, and the commercial enzyme. The smallest squares on 
the paper represent 31.1 m^moles of NADPH. The reaction 
was started by the addition of ICDH(arrow), and oxidation 
occurs in the direction shown. 
(26) 

MALIC ENZYME 
1, Distribution of Enzyme Activity 
Based on the spectrophotome trie reduction of NADP in the presence 
of malate, 94% of the malic enzyme activity in the rat adrenal cell is 
localized in the 100,000g-60 min. soluble supernatant fraction. Follow¬ 
ing sonication the microsomes demonstrate about 1?0, the nuclei 0.6%, and 
the mitochondria 1.3% of the enzyme activity(Table II and Fig. 9). Unlike 
ICDH, mitochondrial ME activity was not spectrophotometrically detectable 
after sonication. Tike specific activity of the enzyme was highest in the 
soluble fraction. Negligible amounts were found in the nuclei, micro¬ 
somes, and mitochondria. Of significance is the 17 fold higher specific 
TABLE II. SUBCELLULAR DISTRIBUTION OF MALIC ENZYME ACTIVITY 
FRACTION TOTAL 
mp moles 
ACTIVITY ° 
NADPH/min. 
{ TOTAL ACTIVITY 
RECOVERED 
SPECIFIC ACTIVITY 
numoles NADPH/min 
mgm. protein 
Initial homogenage 815. 100 10.2 
Nuclei 5.25 0.64 0.757 
Mitochondria 10.5 1.29 0.734 
Microsomes 8.67 1.06 1.59 
Soluble 763. 93.7 23.2 
The 5 subcellular fractions were isolated from the adrenals of 10 rats. 
Each fraction was diluted 4 fold with 0.25 M sucrose and sonicated for 5 min. 
at 30 sec. intervals at 0-4“ C. NADP-linked ME activity was measured spectro¬ 
photometrically at 340 n%J< by the rate of reduction of NADP in the presence 
of 10 mM malate, 10 mM MgCl2, 0.1 M TRIS-HC1, and NADP. 
(27) 
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Figure 9. Subcellular Distribution of Malic Enzyme Activity 
in the Rat Adrenal Cell 
The 5 subcellular fractions were isolated from the adrenals of 
10 rats. Each fraction was diluted 4X with 0.25 M Sucrose and 
sonicated for 5 min. at 30 sec. intervals at 0-4 C. NADP- 
linked ME activity was spectrophotometrically measured at 
340 mp by rate of NADP reduction in the presence of 10 mM 
malate, 10 mM MgCl2, 0.1 M TRIS-HC1, and NADP. 
(28) 
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activity of NADP-linked ICDH over ME in the soluble fraction^Tables 1 and 2). 
The rat adrenal cell thus seems much more capable of utilizing isocitrate 
for extramitochondrial NADPH formation than malate. 
2. Malic Enzyme Activity by Pyruvate Efflux 
Despite the fact that mitochondrial ME activity was not apparent 
spectrophotometrically, we observed the accumulation of pyruvate during 
in vitro incubations of the 100,000g-60 min. supernatant fluid from 
sonicated mitochondria. Pyruvate production versus the length of incubation 
is shown in Fig. 10. 
Using intact rat adrenal mitochondria, Sauer has shown that malate 
supported steroid IIP hydroxylation and pyruvate efflux are augmented by 
the addition of arsenate or P^(34). Thus it seemed that the P^ stimulation 
of pyruvate efflux would result in a situation analagous to O'-ketoglutarate 
efflux during isocitrate oxidation. Fig. 11 shows an experiment in which 
the effect of arsenite upon P^ stimulated pyruvate efflux was assessed. 
Conditions were adjusted for maximal pyruvate efflux: 1) DOC was present 
to act as substrate for steroid hydroxylation. 2) KCN was added to inhibit 
the respiratory chain and to decrease the contribution by the NAD-linked 
malate dehydrogenase(pyruvate might also arise from oxaloacetate, one 
product of MDH), and 3) Arsenite was added to inhibit further oxidation 
of pyruvate. Note that the addition of P^(arrow) caused a marked stimulation 
of pyruvate efflux from the mitochondria. Also, pyruvate accumulated even 
in the absence of arsenite but 1 mM arsenite significantly augmented the 
rate of efflux. Thus we have demonstrated a ME activity based on the efflux 
of pyruvate from intact mitochondria but were unable to show NADP reduction 
(29) 
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Figure 10. Malic Enzyme Activity in Supernatant Fluid of Sonicated Mitochondria 
One flask was incubated at 37° C. with 1.0 ml. aliquots removed 
at 5 min. intervals. Flask contents included: incubation 
medium, 10 mM malate, 10 mM MgC^, 2 mM KCN, 0.05 mM NADP, and 
0.16 mgm. mitochondrial protein/ml. Incubation was begun with 
the addition of malate. The reaction was stopped by adding 
0.1 ml of 70% Perchloric acid to the 1.0 ml aliquots. After 
neutralizing with KOH, pyruvate was measured enzymatically. 
(30) 
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Figure 11. Effect of Arsenite on DOC and P^ Stimulated Pyruvate 
Efflux from Malate Supported Mitochondria 
Two flasks were incubated at 37° C. with aliquots removed at 
4 min. intervals. Reagents included incubation medium, 10 mM 
malate, 100 |JjM DOC, 2 mM P^, 2 mM KCN, ± 1 mM arsenite, and 
0.65 mgm. mitochondrial protein/ml. Malate was added at the 
start of the reaction, and P^ was added as shown. The reaction 
was stopped by centrifuging down the mitochondria. Pyruvate 
was measured in the supernatant fluid by enzymatic methods. 
(3D 

spectrophotometrically in sonicated mitochondria. 
The property of 2 mM P_^ to stimulate pyruvate efflux was a repro¬ 
ducible phenomenon which occurred in 9 different experiments. In 
Fig. 12 the effect of variable P^ concentration upon pyruvate efflux is 
shown. Note the very small for this stimulation of efflux. Also note 
that about 80% of maximal velocity is attained using a P_^ concentration of 
2 mM. 
Presumably, P. activates a membrane transport system for malate so 
that the augmented efflux results from a greater amount of substrate being 
delivered to the mitochondrial matrix space. That pyruvate efflux is 
directly dependent upon the presence of malate is indicated by an experi¬ 
ment in which malate was added to 1 of 2 flasks(Fig. 13). Here, 2 mM P^ 
was present before the malate add it ion(arrow). Note that there was no 
accumulation of pyruvate until malate was added, and the flask without 
malate showed no pyruvate efflux at any time. This experiment proves that 
pyruvate formation is completely dependent upon malate. 
Recently, Robinson and Williams(60) reported that para-iodobenzyl- 
malonate(p-IBM), a structural analogue of malic acid, was effective in the 
inhibition of dicarboxylic acid membrane transport systems. Experiments 
designed to test the efficacy of p-IBM in the inhibition of malate entry 
are shown in Fig. 14 and 15. In Fig. 14, mitochondrial pyruvate efflux 
is shown using 2 flasks, one of which contains 20 mM p-IBM. Note that 
upon addition of P^ pyruvate efflux from the flask containing p-IBM was 
inhibited relative to the pyruvate efflux seen in the control flask. This 
suggests that p-IBM may inhibit the entry of malate into the mitochondria. 
(32) 
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Figure 12. The Effect of P. Concentration upon Pyruvate Efflux 
from Intact Mit&chondria. 
Flasks were incubated for 15 min. at 37° C. Contents included 
incubation medium, 10 mM malate, 2 mM KCN, 0.425 mgm. mito¬ 
chondrial protein/ml., and variable P^ concentration. P^ was 
added at the beginning of the incubation. Pyruvate was measured 
by enzymatic methods after stopping the reaction by centrifuging 
down the mitochondria. 
(33) 
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Figure 13. Dependence of P^ Stimulated Pyruvate Efflux upon Malate 
Two flasks were incubated at 37° C. with the following reagents: 
incubation medium, 2 mM KCN, 2 mM P., 0.3 mgm. mitochondrial 
protein/ml, and ± 10 mM malate(added at arrow). Aliquots were 
removed at 4 min. intervals and the reaction stopped by cent¬ 
rifuging down the mitochondria. The pyruvate in the supernate 
was measured enzymatically. 
(3U) 

m
|JM
ol
es
 
P
y
ru
v
a
te
/m
g
m
. 
p
ro
te
in
 
533 
— p-IBM 
+ p-IBM 
Time of incubation minutes 
Figure 14. Inhibitory Effect of p-IBM upon P^ Stimulated Pyruvate Efflux 
2 flasks were incubated at 37CC. with the following contents: 
incubation medium, 10 mM malate, 2 mM KCN, ± 20 mM p-IBM, 
2 mM P^, and 0.60 mgm. mitochondrial protein/ml. The reaction 
was started by addition of malate, and P^ was added as shown. 
Pyruvate was measured by enzymatic methods. 
(35) 

Fig. 15 demonstrates the effect of p-IBM added at a time when entry and 
oxidation of malate and pyruvate efflux are occurring. 20 mM p-IBM 
caused almost complete inhibition of further pyruvate efflux within 3 
minutes after addition. If p-IBM indeed acts on the membrane transport 
system for dicarboxylic acids, then it seems logical to deduce that 
pyruvate efflux ceases when the intramitochondrial pool of malate becomes 
depleted following the inhibition of malate transport and entry. 
The previous experiments have provided evidence for the presence of 
mitochondrial malic enzyme activity. P_^ has been shown to enhance pyruvate 
efflux, and this in turn is augmented by 1 mM arsenite and DOC and is 
completely dependent upon malate. The results with p-IBM suggest that 
malate enters the mitochondria via a transport system which can be inhibited 
by structural analogues. These experiments, however, demonstrate only 
indirectly the entry of malate into the mitochondria by showing changes 
in efflux of the ME reaction product. 
In an effort to demonstrate the direct entry of malate, mitochondrial 
swelling experiments were carried out using NH^-malate. Chappell(59) has 
+ 
shown that swelling occurs in the following manner: NH^ dissociates 
into H+ and NH3. The latter readily diffuses into the mitochondria 
+ 
where it is protonated to reform the relatively nondiffusable NH^. Malate 
then enters the mitochondria in exchange for the OH which, together with 
the H+ used to protonate NH^, arose from hydrolysis. This influx of NH^- 
malate exerts a solute drag effect and causes influx of water and con¬ 
sequent mitochondrial swelling. This is detectable spectrophotometrically 
at a light wavelength of 600 mu. Fig. 16 shows a typical example where 
(36) 
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Fig. 15. Effect of p-IBM on P^ Stimulated Pyruvate Efflux from 
Malate Supported Mitochondria 
One flask was incubated at 37° C. with the following contents: 
incubation medium, 10 mM malate, 2 mM KCN, 2 mM P^, 20 mM p-IBM, 
and 0.4 mgm. mitochondrial protein/ml. The reaction was started 
by the addition of malate; P^ and p-IBM were added as shown. 
The reaction was stopped by centrifuging down the mitochondria. 
Pyruvate in the supernate was measured by enzymatic methods. 
(37) 

Figure 16. Spectrophotometric detection of mitochondrial swelling 
during NH^-malate incubation. 
Adrenal mitochondria were suspended in a medium containing 
90 mM NH^-malate and 10” ^ M rotenone. 6 mM was added 
(arrow) to initiate the swelling detected at a wavelength 
of 600 mp. The cuvette contained about 0.12 mgm. of 
mitochondrial protein. 
(38) 

P^ stimulated influx of NH^-malate resulted in mitochondrial swelling 
evidenced by the change in optical density. 
Another more definitive technique to directly demonstrate the entry 
of malate into the mitochondria is the use of radioactively labelled com- 
14 
pounds. C labelled malate was incubated with mitochondria in the ususal 
manner. Tritiated water was also included in the incubation to correct 
14 
for uptake due to swelling. Mitochondria were incubated with C -malate 
and aliquots of the suspension were removed at timed intervals. The 
14 3 
mitochondria were quickly spun down, washed, and counted for C and H 
14 
content. The activity of C reflected the intramitochondrial malate 
3 
while the H counts reflected the degree of intramitochondrial water. 
This control was added for it was conceivable that the addition of P^ 
would promote mitochondrial swelling, and the increased intramitochondrial 
14 
space might itself account for any rise in C activity. The determina- 
3 
tion of H -water reflects the water space and would correct for this swell- 
14 
ing. The C label on the malate was so situated as to be removed as 
14 
CO2 during the reaction so that C counts would not leave the mitochondria 
in the form of labelled pyruvate. Fig. 17 demonstrates the radioactivity 
of the mitochondrial pellet during the incubation. Note that upon addition 
14 
of P^ there is a marked rise in pellet C counts suggesting an accumula- 
3 
tion of intramitochondrial malate since H -water indicated no significant 
mitochondrial swelling. This response to P^ is very rapid, peaks by 2 
minutes after addition, then rapidly falls off. It appears as if malate 
enters the mitochondria in one large influx following P. addition. Pyruvate 
determination in the supernatant fluids of this experiment demonstrated a 
simultaneous augmentation in pyruvate efflux following P^. This is 
(39) 
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Figure 17 Effect of P^ on Mitochondrial Accumulation of C 
14 
-Malate 
2 flasks were incubated at 37 C. with the following contents: 
incubation medium, 10 mM malate, 2 mM KCN, 1 mM arsenite, 2 mM P., 
H2O, and 0.76 mgm. mitochondrial protein/ml. 1 flask contained 1 
sufficient labelled malate to give 317,500 cpm/ml. of incub¬ 
ation while the second flask contained H^-water at 330,000 cpm/ml. 
of incubation. The 2 flasks were identical in all other respects. 
% ml. aliquots were removed at the intervals shown and the mitochondria 
centrifuged down in 15 sec. The surface of the pellet was washed 
once and the residual fluid removed. After lysing with perchloric 
acid, 50 pi. of this lysate was counted for radioactivity. 

consistent with malate entry. This experiment provides direct evidence 
for the transport of malate into the mitochondria. Since there is 
ample proof that pyruvate diffuses out of the KCN-inhibited mitochondria, 
and that this is completely dependent on malate(Fig. 13), we can be 
fairly certain that malic enzyme activity is responsible. 
3. Partial Purification of Malic Enzyme and Malate Shuttle Experiments 
It is well known that malate alone will support steroid hydroxylation 
either in the presence of absence of KCN. Since we now know that malate 
can enter the mitochondria and that pyruvate effluxes even in the absence 
of arsenite, the possibility exists that a malate shuttle might be 
operative in rat adrenal mitochondria. Simpson and Estabrook have reported 
a malate shuttle in bovine adrenal cortex mitochondria(53). Especially 
noteworthy is the fact that over 907, of ME activity is present in the sol¬ 
uble cell fraction(Fig. 8). If a malate shuttle exists in the rat, the 
abundant soluble ME should reform malate from pyruvate, HCO3, and NADPH 
in the presence of Mn in amounts great enough to support steroid hydroxy¬ 
lation. 
The supernatant ME was purified and concentrated as follows: Those 
fractions from the 100,000g-60 min. supernate precipitating between 65 
and 877o of saturation with ammonium sulfate were dialyzed against 30 mM 
+ 
TRIS-HC1 to remove NH^. After concentrating this enzyme solution, the 
purification of ME activity approached 14 fold. This partially purified 
enzyme plus the reactants necessary for the formation of malate from 
pyruvate were used to reconstruct the malate shuttle as described in Table III. 

After a 15 minute incubation the samples were assayed for corticosterone 
formation from DOC. Control flasks lacking certain of the reactants were 
incubated simultaneously. The results are shown in Table III. 
The complete system which contained all reactants generated a 2-3 fold 
greater quantity of B than any of the controls(with the exception of the 
one lacking NADPH and HCO3). 
The finding that MS from the adrenal cell soluble fraction will use 
pyruvate + HCO^ + NADPH and support steroid hydroxylation is tentative 
evidence that a functional malate shuttle may well exist in the rat adrenal 
TABLE III. Corticosterone Formation Supported by 
Extramitochondrially Generated Malate. 
FLASK nanogm. B formed/ml. incubation 
medium 
Complete system 13,920 
w/out Pyruvate, HCO3, NADPH, ME 3,860 
w/out Pyruvate, HCO3, NADPH 6,640 
w/out Pyruvate 6,040 
w/out HC03, NADPH 9,420 
w/out ME 4,040 
Flasks incubated in duplicate contained the following reactants: the 
concentrated enzyme, 10 mM pyruvate, 50 mM HCO3, 5 mM Mg , 2 mM P-^, 1 mM 
arsenite, 2 mM KCN, 300 p,M DOC, an NADPH generating system of 0.5 mM NADPH, 
10 mM glucose-6-PO^, and glucose-6-PO^ dehydrogenase, and the incubation 
medium. Flasks contained 0.8 mgm. mitochondrial protein/ml. A preincubation 
lasted 7 minutes at 37^ C., and mitochondria were added at zero time to start 
the 15 minute incubation period. The reaction was terminated by addition of 
1.0 ml. of 0.5% HgCl2 and icing. Samples were then assayed for content of B. 

In order to substantiate this finding, the same experiment was repeated 
on two other occasions utilizing soluble ME partially purified from 
separate batches of pooled soluble supernatants. The experiments were 
altered somewhat to show the progression of B formation over time, but 
results to confirm the original finding were unsuccessful. 
The results of the original experiment implied that malate was 
formed; therefore, NADPH should have been oxidized during the reaction. 
To confirm that this was actually occurring, the partially purified ME 
was incubated with NADPH in the presence of pyruvate and other factors 
included in the shuttle reaction. As shown in Fig. l8, NADPH oxidation 
was observed spectrophotometrically. This provides further evidence that 
ME may indeed catalyze the reverse reaction. As in the case of ICDH, the 
oxidation of NADPH should continue at a reasonably constant rate if there 
were a continual regeneration of NADP. This spectrophotometric evidence 
that ME can oxidize NADPH in the presence of pyruvate and HCO^ lends 
credibility to the successful demonstration of the malate shuttle experiment. 
In summary, all the in_ vitro results obtained with ME indicate that 
a malate shuttle is functionally possible in rat adrenal mitochondria. 
Malate entry into the mitochondria is stimulated by P and inhibited by 
i 
p-IBM. Mitochondrial ME activity can support steroid hydroxylation and 
result in accumulation and diffusion of pyruvate from the mitochondria. 
This is enhanced by the presence of arsenite and DOC. Pyruvate can be re¬ 
converted to malate by the ME of the soluble cell fraction in amounts 
sufficient to support mitochondrial steroid hydroxylation. A schematic 
representation of the possible pathways suggested by these results is shown. 
(U3) 

Figure 18. Spectrophotometric Oxidation of NADFH by Soluble 
Malic Enzyme in the Presence of Pyruvate. 
-H- - 
Cuvette contained 4 mM pyruvate, 10 mM Mg , 50 mM HCO^, 
NADPH, and the partially purified soluble ME. The reaction 
was started by the addition of ME(arrow), and oxidation of 
NADPH at 340 up, occurs in the direction shown. The smallest 
squares on the paper represent 31.1 mp-moles of NADPH. 

Figure 19- A Schematic Representation of the Malate Shuttle in the 
Rat Adrenal Mitochondria and Soluble Fraction 
P450 pathway and 
Steroid 
Hydroxylation 
NADH 
(44) 

DISCUSSION 
These data have demonstrated and clarified the role of non-energy 
dependent mechanisms in providing intramitochondrial NADPH for rat 
adrenal steroid hydroxylation. The results outline certain biochemical 
features of isocitrate and malate metabolism in relation to steroidogenesis, 
and evidence is presented to support the existence of a functional malate 
shuttle. 
NADP-1inked ICDH has been shown to have an essentially bimodal 
distribution in various animal tissues with the soluble fraction account¬ 
ing for 80-90% of the activity and the remainder being localized in the 
mitochondria. This is true in rat and mouse liver(35,36), bovine adrenal 
(39), human placenta(38), and human adrenal(24). Our data demonstrate 
an essentially similar distribution of the enzyme in the rat adrenal with 
almost 20% of the activity located in the mitochondria. 
Although the distribution of NADP-linked ICDH is basically similar 
in these tissues, different opinions exist regarding the mitochondrial 
pathways of isocitrate oxidation. For example, in rat liver tissue there 
is evidence that either the NAD or NADP linked pathways may predominate 
during isocitrate oxidation(36,61). On the other hand, Grant has shown 
(US) 

that the NAD-linked MDH is the major pathway in bovine adrenal mitochondria 
(62). He provided additional evidence that isocitrate was a poor substrate 
for steroid IIP hydroxylation and therefore implied that the transhydro- 
genase activity was low. Our data in the rat adrenal show the NADP-linked 
ICDH to be highly active in the oxidation of isocitrate not only in the 
soluble fraction but in the mitochondria as well. The high rates of NADPH 
formation and Q'-ketoglutarate efflux observed with the mitochondrial ICDH 
are consistent with the observations of others(11,23,34) that isocitrate, 
of all Krebs cycle intermediates, supports the highest rates of 113 
hydroxylation. In addition, respiratory chain inhibitors have little or 
no effect on these rates suggesting that the NAD-linked pathway is of 
minor significance during steroid hydroxylation. 
Of interest is the fact that mitochondria possess only \TL of the 
total NADP-linked ICDH activity. Furthermore, NAD-linked MDH is located 
exclusively in the mitochondria. That isocitrate seems to be preferent¬ 
ially oxidized by the NADP-linked ICDH during steroid hydroxylation may 
reflect a unique evolutionary development in the rat whereby steroido- 
gensis is virtually independent of oxidative phosphorylation. The advantage 
of such a situation may be manifest during periods of limited substrate 
availability which might preclude simultaneous activity of both the P450 
and the classic electron transport pathways. 
The purpose of a soluble NADP-linked ICDH is not fully appreciated. 
Goebell and Pette(39) suggested that it is related to glycolysis and 
serves to regulate citrate in the cytoplasm. Another possible function 
of the enzyme may be provision of NADPH for the microsomal NADPH-dependent 

17 and 21 hydroxylations. This takes on additional significance consid¬ 
ering recent findings from Harding's laboratory(63). These workers 
assayed crude rat adrenal homogenates for Krebs cycle intermediates and 
found isocitrate by far the most abundant substrate present. In addition 
to the possibilities mentioned, we feel that the presence of this highly 
active soluble enzyme may imply a shuttle for NADPH. Despite the fact 
that we were unable to demonstrate its support of steroid hydroxylation, 
spectrophotometric evidence shows that the shuttle is biochemically 
feasible. Once again, it should be emphasized that _in vitro laboratory 
techniques can only approximate, at best, the actual intracellular milieu. 
On the spectrophotometric basis of NADPH production, virtually all 
of the ME activity in sonicated rat adrenal tissue is localized in the 
soluble fraction; yet mitochondrial enzyme activity is clearly manifest 
on the basis of P. stimulated pyruvate efflux during incubations with 
intact mitochondria. This paradoxical situation apparent with ME is not 
easily explained. Others have interpreted pyruvate efflux from bovine adrenal 
mitochondria to reflect malic enzyme activity(51,64), but no dependence 
on Pi was demonstrated. Using rat adrenal mitochondria, Purvis(40) and 
Peron(50) both provided evidence that ME was not an important pathway for 
malate oxidation. On the other hand, Sauer(34) found tflnat in rat adrenal 
mitochondria ME could contribute about half the NADPH for steroid 11(3 
hydroxylation when this pathway was stimulated by P^(the remaining NADPH 
originating from MDH and the ELTH). However, unlike other mitochondrial 
enzymes, ME could not be demonstrated following sonication. These findings 
led Sauer to conclude that P^ activated a malic enzyme-like activity. Our 
data confirm certain of these observations: ME indeed could not be 
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demonstrated in the mitochondria following sonication(Fig.9). However, 
we were able to demonstrate ME activity in the supernatant fluid of 
sonicated mitochondria which had been centrifuged at 100,000g for 60 min- 
utes(Fig. 10). This procedure eliminated the disrupted mitochondrial 
membrane fragments. Despite the presence of KCN in the cuvette these 
membranes interfered with the spectrophotometric assay for ME. Our find¬ 
ings therefore suggest that ME is indeed present. 
The mechanism of the P^ effect has been recently explored by Chappell 
(59). He feels that malate, a dicarboxylic anion, can only penetrate the 
mitochondrial membrane by exchanging for another similarly charged anion 
-2 
such as HPO^ . Since P^ easily penetrates the membrane in exchange for 
OH , the presence of adequate intramitochondrial phosphate anions permits 
malate entry. Why this P^ requirement for malate entry is seen in rats 
but not bovine mitochondria is unclear; but Sauer feels that bovine 
mitochondria may contain sufficient endogenous phosphate to exceed the 
relatively small 1^ for this activation(34). 
The possibility exists that the pyruvate efflux witnessed in our 
experiments may be a result of MDH activity rather than ME. This could 
occur if the mitochondria also contained an oxaloacetate decarboxylase or 
a NAD-linked decarboxylating malic dehydrogenase. However, these possi¬ 
bilities seem unlikely since P^ stimulated pyruvate efflux occurs in the 
presence of respiratory chain inhibitors(Fig. 11) which would tend to 
inhibit the NAD-linked oxidation. In addition, malate supported IIP 
hydroxylation is only partly inhibited by KCN(34), suggesting that the 
uninhibited contribution is the NADP-linked energy independent ME. 

We have provided the first evidence that a functional malate shuttle 
may exist in the rat adrenal for support of steroid hydro xylation. This 
was originally proposed by Peron, but he subsequently was unable to 
demonstrate its existence. The attempts to confirm our original finding 
were unsuccessful. Although the reasons are unclear, one possible explan¬ 
ation may be that the 2 mM P^ used in the experiments actually inhibited 
the support of steroid hydroxylation by the small amount of malate formed. 
Sauer has shown(65) that when malate concentrations are very low--in the 
range of 0.1 mM--the presence of 2 mM P^ inhibits steroid hydroxylation. 
It is not until higher malate concentrations are reached that P has a 
l 
stimulating effect. Thus, unless our incubations with the concentrated 
soluble ME generated sufficient malate, it is unlikely that steroid 
hydroxylation beyond control values would have been demonstrated. 
The possible existence of a malate shuttle in the rat adrenal pro¬ 
vides an efficient mechanism whereby the translocation of substrates can 
mediate the transfer of extramitochondrially generated NADPH to the intra- 
mitochondrial space for steroid hydroxylation. Such a mechanism might 
allow the continued formation of active steroids without interfering 
with the oxidation of Krebs cycle intermediates via oxidative phosphory¬ 
lation. The advantage of this situation would be manifest during periods 
of stress when both active steroid hydroxylation and oxidative phosphory¬ 
lation are necessary. Energy independent reactions would allow the 
dissociation of the two pathways. 
Harding’s data referred to earlier(63) concerning Krebs cycle substrate 
present in rat adrenal homogenates showed that citrate-isocitrate concen¬ 
trations were very high. In addition, malate was present in concentrations 

8 fold higher than oxaloacetate and cy-ketoglutarate. Citrate-isocitrate 
was twice as abundant as malate. The presence of these two substrates in 
such high concentrations emphasizes their importance in adrenal cell 
function especially when viewed in light of current data concerning the 
roles of isocitrate and malate in steroidodgenesis. 
Until very recently, there was no available data regarding isocitrate 
and malate metabolism in relation to the effects of ACTH. Laury and 
McCarthy(66), however, have administered long term ACTH injections to rats 
and demonstrated the mitochondria to have an increased capacity to 
utilize isocitrate, succinate, and especially malate for the support of 
11)3 hydroxylation. These findings suggest that ACTH can increase the 
levels of specific mitochondrial enzymes, thus providing additional 
evidence that NADP-linked ICDH and ME may play key roles in steroid 
hydroxylation. 
Our findings on non-energy dependent mechanisms-ICDH and ME-in the 
rat adrenal demonstrate some biochemical features of isocitrate and 
malate metabolism in relation to steroid hydroxylation. The data pro¬ 
vide additional support to the important role which these mechanisms 
play in the overall scheme of steroid hydroxylation. 
(50) 

SUMMARY 
The following points have been established from the experimental results 
presented in this thesis: 
1. NADP-linked ICDH and ME constitute two non-energy dependent enzymes 
which produce intramitochondrial NADPH for rat adrenal steroid hydroxylation. 
2. ICDH and ME activities are evident in both the mitochondria and 
soluble cell fractions. 
3. Q'-ketoglutarate formed by ICDH can diffuse out of the mitochondria 
in the absence of arsenite, and this efflux is augmented by steroid hydroxylation. 
4. There is spectrophotometric evidence that ICDH can catalyze the 
formation of isocitrate from Q'-ketoglutarate, HCO^, and NADPH, but this does 
not occur at rates sufficient to support steroid hydroxylation _in vitro. 
5. p-IBM can inhibit the P. stimulation of malate entry into the mitochondria. 
6. Mitochondrial ME activity can support steroid hydroxylation and result 
in accumulation and efflux of pyruvate from the mitochondria. This efflux 
is augmented by arsenite and DOC. 
7. There is _in vitro and spectrophotometric evidence that soluble fraction 
ME can make malate from pyruvate, HCO^, and NADPH. The malate is formed in 
sufficient amounts to support steroid hydroxylation. This constitutes tentative 
evidence that the malate shuttle is operative in the rat adrenal gland. 
(5D 
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